v3.26.1
Net Income (Loss) Per Share
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Net Income (Loss) Per Share

Note C – Net Income (Loss) Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except for per share data):

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Amounts used for basic and diluted per share calculations:

 

 

 

 

 

 

Net income (loss) attributable to Agenus Inc. common stockholders

 

$

39,172

 

 

$

(25,320

)

 

 

 

 

 

 

 

Weighted average number of Agenus Inc. common shares outstanding - basic

 

 

37,941

 

 

 

24,469

 

 

 

 

 

 

 

 

Effect of potentially dilutive securities:

 

 

 

 

 

 

    Share based compensation awards

 

 

341

 

 

 

 

    Warrants

 

 

3

 

 

 

 

Weighted average number of Agenus Inc. common shares outstanding - diluted

 

 

38,285

 

 

 

24,469

 

 

 

 

 

 

 

 

Net income (loss) attributable to Agenus Inc. per common share:

 

 

 

 

 

 

    Basic

 

$

1.03

 

 

$

(1.03

)

    Diluted

 

$

1.02

 

 

$

(1.03

)

Basic net income (loss) per common share is calculated by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding (including common shares issuable under our Amended and Restated Directors’ Deferred Compensation Plan, or “DDCP”). Diluted income (loss) per common share is calculated by dividing income (loss) attributable to common stockholders by the weighted average number of common shares outstanding (including common shares issuable under our DDCP) plus the dilutive effect of outstanding instruments such as warrants, stock options, non-vested shares and convertible preferred stock. Because we reported a net loss attributable to common stockholders for the three months ended March 31, 2025, diluted loss per common share is the same as basic loss per common share, as the effect of utilizing the fully diluted share count would have reduced the net loss per common share. The following securities (listed on an as-if-converted-to-Common-Stock basis) have been excluded from the computation of diluted weighted average shares outstanding as of March 31, 2026 and 2025, as they would be anti-dilutive (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Warrants

 

 

1,029

 

 

 

1,032

 

Stock options

 

 

4,622

 

 

 

5,193

 

Non-vested shares

 

 

4

 

 

 

44

 

Series A-1 convertible preferred stock

 

 

17

 

 

 

17